2013 PED Dr Kolfenbach

E-Newsletter Signup

Please leave this field empty

Local Resources


University of Colorado Scleroderma ProgramCO Jewish Health

Aurora/DenverCO Anschutz
University of Colorado Anschutz Medical Campus, Division of Rheumatology, Barbara Davis Center, 1775 Aurora Court, P.O. Box 6511, Mail Stop B-115, Aurora, Colorado 80045

University of Colorado Rheumatology, http://www.ucdenver.edu/academics/colleges/medicalschool/departments/medicine/Rheumatology/Pages/Rheumatology.aspx

Physicians Afilliated with this Center:

  • Aryeh Fischer, M.D. (U of CO)
  • Jason Kolfenbach, M.D. (U of CO)

Clinic Information: Hours: M–F 8:00 a.m. to 5:00 p.m.
Contacts: University of Colorado: (720) 848-7700 or 720-848-4400

Studies Status

PHAROS (Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma)




Rituximab in SSc-APAH: A Randomized, Double-blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) in the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension


Ambition trial for PAH


Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma-Associated Pre-Pulmonary Arterial Hypertension


A Phase II Multi-Center Study of High-Dose Cyclophosphamide and Antithymocyte Globulin Followed by Autologous Hematopoietic Cell Transplantation for the
Treatment of Systemic Sclerosis (STAT study)


LOTUSS: An Open-Label, RandOmized, Phase 2 STUdy of the Safety and Tolerability of Pirfenidone when Administered to Patients with Systemic Sclerosis-Related Interstitial Lung Disease


Other studies related to scleroderma: http://pulmonaryfibrosisresearch.org/

Click to learn more about Scleroderma Centers >>